Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Science Group posts record first-half adjusted operating profit
(Sharecast News) - Science Group reported a record adjusted operating profit of £11m for the six months ended 30 June on Tuesday, up from £10.4m a year earlier. The AIM-traded firm said its adjusted basic earnings per share increased to 18.1p, compared to 16.6p last year.
Its cash position strengthened, with group cash at £38.8m and net funds at £26.4m, benefiting from strong cash conversion.
A significant contributor to the performance was the turnaround at CMS2, which now reported increased revenue and profitability.
CMS2's revenue for the period was £10.9m, a rise from £7.9m in the first five months of 2023, with adjusted operating profit surging to £3.2m from £0.8m.
That improvement was attributed to strategic management actions and increased investment in innovation, resulting in 12 new patents filed in 2024.
Science Group's consultancy division faced a challenging market, with first-half revenue at £36.5m, down from £42.3m in the first half of 2023, due to large projects concluding and a broader market slowdown.
Despite that, the division maintained strong margins, with adjusted operating profit at £8.8m, consistent with the second half of 2023.
The medical sector showed sequential growth, while the Industrial sector remained subdued, and the defence sector experienced a decline due to reduced legacy low-margin activities and a slowdown in discretionary spending.
Frontier, a subsidiary focused on radio and audio semiconductors, reported revenue of £5.9m, up from £5.4m in the first six months of 2023 and £4.5m in the second half of the same year.
The business achieved operating breakeven while continuing to invest in research and development.
Frontier launched a new connected-audio product, Auria, and maintained market leadership in the traditional radio market.
Science Group also announced an increased share buyback programme of up to £5m.
"The first half of 2024 has continued the group's consistent track record, delivering record first-half adjusted operating profit, with strong cash conversion, despite ongoing economic and political uncertainty," the Science Group board said in its statement.
"This solid performance provides a good platform for the remainder of the year.
"The operating improvements and financial performance delivered by CMS2 are particularly noteworthy."
At the same time, Science Group said its consultancy division had demonstrated resilience in a "more unpredictable" market environment, adding that the anticipated Frontier recovery was progressing.
"With a robust balance sheet, including significant cash resources and undrawn debt facilities, combined with ongoing operating cash generation, Science Group continues to explore corporate opportunities while also increasing the capital allocated to the share buy-back programme."
At 1147 BST, shares in Science Group were down 0.05% at 414.8p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.